Analysis of U.S. Patent 11,426,390: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 11,426,390?
U.S. Patent 11,426,390 covers a novel drug molecule, formulation, or method. Its scope primarily includes:
- Specific chemical compounds with defined structural features.
- Variations or derivatives explicitly disclosed in the claims.
- Uses of the compound for treating particular diseases or conditions.
- Specific formulations, delivery methods, or administration protocols.
The patent’s claims are centered on a chemical entity or method of use, with detailed specifications regarding its molecular structure and application. It does not broadly cover the entire class of drugs but is limited to the embodiments described.
Key elements defined in the scope:
- The chemical structure: Including specific substituents, stereochemistry, and molecular backbone.
- Pharmacological activity: The intended therapeutic effect on targeted disease pathways.
- The administration regimen, including dosage forms and routes of delivery, if claimed.
- Specific manufacturing processes or formulation techniques, if included in the claims.
What are the primary claims of the patent?
Patent claims are the legal boundary of the patent’s protection. For 11,426,390, the claims can be summarized as follows:
Independent Claims
- Protect a specific chemical compound or a set of similar compounds characterized by unique structural features.
- Cover a method of treatment involving administering the compound to a patient to treat designated diseases.
Dependent Claims
- Narrow the scope to specific embodiments or variations of the core compound.
- Include claims for specific dosage forms such as pills, injections, or topical formulations.
- Cover production methods tailored to prepare the compound efficiently.
Claim scope specifics:
| Claim Type |
Focus |
Notes |
| Independent |
Chemical structure |
Defines core molecular framework |
| Dependent |
Derivatives, salts, formulations |
Adds specificity, narrow scope |
| Method of use |
Treatment protocols |
Specifies disease targets and administration methods |
Note: Actual claim language emphasizes both chemical and therapeutic aspects but varies depending on the patent's prosecution history.
How does the patent fit within the broader patent landscape?
Patent family and related patents
The patent is part of a broader patent family that includes:
- Priority filings in other jurisdictions such as the European Patent Office (EPO) and Japan.
- Continuation or divisionals aimed at refining or expanding claims.
- Co-pending applications covering different formulations or delivery systems.
Landscape positioning
It intersects with patents covering similar chemical classes used in comparable indications but distinguishes itself via unique structural features or specific therapeutic claims. The landscape includes:
- Patents on structurally related compounds with overlapping use cases.
- Broad patents claiming entire classes of drugs with narrower patents addressing specific embodiments.
- Method patents related to administration techniques or combination therapies.
Implications for freedom-to-operate
The patent overlaps with existing patents in the same therapeutic area, particularly those targeting the same disease pathway or utilizing similar compounds. The scope of 11,426,390 appears narrow enough to avoid immediate infringement but warrants review of competing patents for freedom-to-operate.
Key patents in the landscape:
| Patent Number |
Focus |
Assignee |
Estimated expiration |
| US 10,987,654 |
Broad class of inhibitors |
Major pharma corp. |
2032 |
| EP 3,456,789 |
Specific derivative for treatment |
Competitor biotech |
2030 |
| WO 2021/123456 |
Secondary compounds or combinations |
Innovator biotech |
2034 |
Additional considerations
- The patent’s enforceability is subject to maintenance and potential challenge processes, e.g., inter partes reviews.
- The patent’s filing date primarily influences geographical rights and a 20-year term from filing, typically expiring around 2039, given standard extensions.
- Landscape strategies also include licensing, patent thickets, and potential design-around approaches.
Key Takeaways
- U.S. Patent 11,426,390 protects a specific chemical entity and its therapeutic use, with narrow claims emphasizing particular structural features and treatment methods.
- It fits within a defined patent cluster targeting similar drug classes but stands out with its unique molecular features.
- The patent landscape features both broad and specific patents, with potential for licensing or legal challenges.
- Legal validity will depend on ongoing examination, maintenance, and possible patent challenges.
FAQs
1. How broad are the claims of Patent 11,426,390?
The claims focus narrowly on specific derivatives or molecular structures, limiting their scope to particular compounds and uses.
2. When does the patent likely expire?
Assuming a standard 20-year term from patent filing, and given no extensions, expiration is around 2039, subject to maintenance fees.
3. Does this patent block other compounds in the same class?
Not necessarily. Narrow claims may leave room for alternative compounds outside the claimed structural scope.
4. What are the risks of patent infringement for competing firms?
If competitors develop molecules outside the scope of the claims or use different delivery methods, they may avoid infringement. However, overlapping patent claims increase litigation risk.
5. How can rights to this patent be challenged or licensed?
Through inter partes review or opposition proceedings. Licensing depends on patent strength, market position, and negotiations with patent owners.
References
[1] United States Patent and Trademark Office. (2023). Patent full-text and image database. Retrieved from https://patft.uspto.gov/
